The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine.

We tested the hypothesis that transdermal scopolamine increases vagal-cardiac nervous outflow over the long term in 16 healthy young men. Twenty-four hours after application of one scopolamine patch, the average RR interval was increased by 13% and the average standard deviation of the RR interval (taken as an index of the level of vagal-cardiac nervous activity) was increased by 31%. Baroreceptor-cardiac reflex responsiveness (as reflected by prolongation of RR interval provoked by graded neck suction) also was increased substantially. These findings suggest that vagal-cardiac nervous activity can be augmented pharmacologically in man on a long-term basis. Since vagal outflow influences cardiac electrical properties in an important way, these findings may have therapeutic implications.

[1]  B Lown,et al.  Neural activity and ventricular fibrillation. , 1976, The New England journal of medicine.

[2]  D. Eckberg,et al.  Trigeminal‐baroreceptor reflex interactions modulate human cardiac vagal efferent activity. , 1984, The Journal of physiology.

[3]  J. Gravenstein,et al.  Effects of Atropine and Scopolamine on the Cardiovascular System in Man , 1964, Anesthesiology.

[4]  R. Miller,et al.  Ventricular fibrillation and tachycardia after intravenous atropine for treatment of bradycardias. , 1972, New England Journal of Medicine.

[5]  D. Ewing,et al.  MORTALITY IN DIABETIC AUTONOMIC NEUROPATHY , 1976, The Lancet.

[6]  D. Jordan,et al.  Synaptic mechanisms involved in the inspiratory modulation of vagal cardio‐inhibitory neurones in the cat. , 1984, The Journal of physiology.

[7]  W. J. Langford Statistical Methods , 1959, Nature.

[8]  R. Tarazi,et al.  Assessment of parasympathetic control of heart rate by a noninvasive method. , 1984, The American journal of physiology.

[9]  S. Epstein,et al.  Neural basis for the genesis and control of arrhythmias associated with myocardial infarction. , 1976, Cardiology.

[10]  G. Varigos,et al.  Sinus Arrhythmia in Acute Myocardial Infarction , 1978, The Medical journal of Australia.

[11]  Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. , 1981, The New England journal of medicine.

[12]  C Antzelevitch,et al.  Electrotonic Modulation of Pacemaker Activity Further Biological and Mathematical Observations on the Behavior of Modulated Parasystole , 1982, Circulation.

[13]  E. Prystowsky,et al.  Enhanced parasympathetic tone shortens atrial refractoriness in man. , 1983, The American journal of cardiology.

[14]  F. Pérez-Gómez,et al.  Prinzmetal's angina:reflex cardiovascular response during episode of pain. , 1979, British heart journal.

[15]  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.

[16]  P G Katona,et al.  Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. , 1975, Journal of applied physiology.

[17]  R. Winkle,et al.  The Relationship Between Ventricular Ectopic Beat Frequency and Heart Rate , 1982, Circulation.

[18]  L. Wilhelmsen,et al.  Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. , 1974, Lancet.

[19]  J. C. Bailey,et al.  Parasympathetic effects on electrophysiologic properties of cardiac ventricular tissue. , 1983, Journal of the American College of Cardiology.

[20]  D L Eckberg,et al.  Baroreflex inhibition of the human sinus node: importance of stimulus intensity, duration, and rate of pressure change. , 1977, The Journal of physiology.

[21]  P. Corr,et al.  Autonomic neural influences on the dysrhythmias resulting from myocardial infarction. , 1978, Circulation research.

[22]  P. Schweitzer,et al.  Termination of ventricular tachycardia by carotid sinus massage. , 1983, Chest.

[23]  M E McCauley,et al.  Effect of transdermally administered scopolamine in preventing motion sickness. , 1979, Aviation, space, and environmental medicine.

[24]  J E Shaw,et al.  Pharmacokinetics of drug permeation through human skin. , 1978, Journal of pharmaceutical sciences.

[25]  K. Swedberg,et al.  EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.

[26]  H. L. Stone,et al.  The effects of daily exercise on susceptibility to sudden cardiac death. , 1984, Circulation.

[27]  L. Rydén,et al.  A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. , 1983, The New England journal of medicine.

[28]  K. Kent,et al.  Electrical Stability of Acutely Ischemic Myocardium: Influences of Heart Rate and Vagal Stimulation , 1973, Circulation.

[29]  L. Hinkle,et al.  Slow heart rates and increased risk of cardiac death in middle-aged men. , 1972, Archives of internal medicine.

[30]  D. Lipson,et al.  Opposing central and peripheral effects of atropine on parasympathetic cardiac control. , 1977, The American journal of physiology.

[31]  D L Eckberg,et al.  Human sinus arrhythmia as an index of vagal cardiac outflow. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[32]  G. Moe,et al.  Adrenergic Effects on Ventricular Vulnerability , 1964, Circulation research.

[33]  D L Eckberg,et al.  A simplified neck suction device for activation of carotid baroreceptors. , 1975, The Journal of laboratory and clinical medicine.

[34]  D L Eckberg,et al.  Muscarinic cholinergic receptors modulate vagal cardiac responses in man. , 1983, Journal of the autonomic nervous system.

[35]  M B Waxman,et al.  Termination of Ventricular Tachycardia by an Increase in Cardiac Vagal Drive , 1977, Circulation.

[36]  H. L. Stone,et al.  Baroreceptor Reflex Control of Heart Rate: A Predictor of Sudden Cardiac Death , 1982, Circulation.